Surmounting chemotherapy and radioresistance in chondrosarcoma: Molecular mechanisms and therapeutic targets

Francis Y. Lee, Anne C. Onishi, Alexander M. Hincker

Research output: Contribution to journalReview article

34 Scopus citations

Abstract

Chondrosarcoma, a primary malignancy of bone, has eluded successful treatment with modern chemotherapeutic and radiation regimens. To date, surgical resection of these tumors remains the only curative treatment offered to patients with this diagnosis. Understanding and exploring the nature of chemotherapy and radiation resistance in chondrosarcoma could lead to new molecular targets and more directed therapy for these notoriously difficult-to-treat tumors. Here we review the most current hypotheses regarding the molecular mechanisms mediating chemotherapy and radiation resistance and the future direction of chondrosarcoma therapy research.

Original languageEnglish
Article number381564
JournalSarcoma
Volume2011
DOIs
StatePublished - Mar 8 2011
Externally publishedYes

Fingerprint Dive into the research topics of 'Surmounting chemotherapy and radioresistance in chondrosarcoma: Molecular mechanisms and therapeutic targets'. Together they form a unique fingerprint.

  • Cite this